Shanghai Hile Bio-Technology Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 231.35 million compared to CNY 294.12 million a year ago. Revenue was CNY 240.72 million compared to CNY 299.99 million a year ago.

Net income was CNY 62.87 million compared to CNY 121.61 million a year ago. Basic earnings per share from continuing operations was CNY 0.1 compared to CNY 0.19 a year ago. Diluted earnings per share from continuing operations was CNY 0.1 compared to CNY 0.19 a year ago.